Injection 100 units/mL,
Penfill® cartridge for Fiasp® devices
Flextouch® prefilled disposable injection devices
Fiasp® and NovoRapid® are not interchangeable due to differences in bioavailability.

Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin.
Insulin Aspart (Fiasp®) is recommended for the treatment of diabetes mellitus in adults who are suitable for NovoRapid® and their diabetes cannot be adequately managed with alternative formulary choices and at least one of the following applies:
- where the prescriber believes a faster onset of action would be beneficial to the patient
- where a patient requires ‘tight’ control of blood sugar levels
- where a patient has rapid post meal increase in blood sugar levels

Injection 100 units/mL,

Solution for injection in vial

Solution for injection in cartridge

KwikPen® solution for injection in pre-filled pen

Junior KwikPen® solution for injection in pre-filled pen

Insulin Lispro (Lyumjev®) is recommended for the treatment of diabetes mellitus in adults who are suitable for Humalog® and their diabetes cannot be adequately managed with alternative formulary choices and at least one of the following applies:

-Where the prescriber believes a faster onset of action would be beneficial to the patient
- Where a patient requires ‘tight’ control of blood sugar levels
- Where a patient has rapid post-meal increase in blood sugar levels

First choice insulin aspart in new users

10mL vial
3mL cartridge for NovoPen®
3mL prefilled disposable FlexPen®

Biosimilars are first line